European Archives - Page 686 of 1062 - European Medical Journal

An Interview with Roslyn Schneider

An interview with Roslyn Schneider, Former Global Patient Affairs Lead, Pfizer, at this year’s eyeforpharma, Barcelona conference.

An Interview with Kasper Jerlang from LEO Pharma

An interview with Kasper Jerlang, Head of Global Digital Marketing and Engagement, LEO Pharma, at this year’s eyeforpharma, Barcelona conference. Kasper speaks about his role in digital marketing at LEO as well as the company culture and his approach to leadership.

Skin Could Play a Major Role in Chronic Diseases

KEEPING skin moisturised and in good condition could decrease the risk of several chronic conditions such as heart disease, Alzheimer’s, and diabetes..

Fungi Species Key in Development of Atopic Dermatitis

YEAST species responsible for protection against fungi on the skin is also pivotal in the development of atopic dermatitis symptoms..

EMJ Hematology 7 [Suppl 1] 2019

Prof Salles provided an update on the ongoing first-line follicular lymphoma (FL) studies, demonstrating how analysis of the GALLIUM study data regarding…

Expectations and Experience: Optimising Efficacy and Maintaining Quality of Life in Follicular Lymphoma

Prof Salles provided an update on the ongoing first-line follicular lymphoma (FL) studies, demonstrating how analysis of the GALLIUM study data regarding…

“Medical Affairs has a Central Role to Play in Building Trust Between Doctors and Healthcare Stakeholders and the Pharmaceutical Industry”

Cesar Sanz Rodriguez is Associate Vice President, Medical Affairs Lead Mid-Europe (MER), Eastern Europe, Middle East & Africa (EEMEA) Regions. He spoke to us about his progression into medical affairs from a clinical background, the changing role of medical affairs in the pharma industry, and the exciting advances currently taking place in cancer treatment.

Importance of screening for early-onset colorectal cancer

RESEARCH into early-onset colorectal cancer (CRC) has found unique subgroups among younger patients and has outlined risk factors and prevalence of…

Obesity-targeting procedures can lower cancer risk in women

Obesity is a known risk factor for a multitude of cancers, including pancreatic, ovarian, and liver, and contributes to an estimated 15–20% of all cancer…

New Insights into Prostate Cancer Treatment

ANDROGEN deprivation therapy (ADT) is commonly used for the treatment of metastatic hormone sensitive prostate cancer (mHSPC)…